CD80 and neoplasm: CD80, a co‐stimulatory molecule on activated antigen‐presenting cells, was more abundant in the tumor microenvironment of saline‐treated mice, reflecting active immune response, while the long‐term survivors from the combination therapy group had fewer CD80+ cells, indicating decreased immune activation due to effective tumor control.